Preventive Medicine News

The U.S. Preventive Services Task Force issued updated recommendations for colorectal cancer screening in JAMA.

Among patients with atherosclerotic CVD, there was no difference in CV events or major bleeding according to aspirin dose, researchers reported at the American College of Cardiology Scientific Session.

The pandemic has disrupted HIV care, including routine testing. By making phlebotomy part of the COVID-19 testing process, an ED at the University of Chicago Medicine kept up its HIV screening volumes during the pandemic, data show.

In a cohort of Chinese patients with normal kidney function at baseline, NSAIDs had varying impacts on eGFR decline, with ibuprofen posing the lowest risk and etoricoxib posing the highest risk.

In a rural health system, more than half of patients with atrial fibrillation did not receive treatment consistent with guidance from the American Heart Association, American College of Cardiology and Heart Rhythm Society, data show.

Patients with five or more comorbidities were less likely to receive screening for colorectal cancer, according to research published in the Journal of Osteopathic Medicine.

The U.S. Preventive Services Task Force announced that supplementation with vitamin E provides no benefit and the harms of beta-carotene supplementation outweigh any benefits for the prevention of CVD and cancer.

In this video, Nitin Damle, MD, MS, MACP, past president of the ACP, discusses highlights from his presentation at the virtual ACP Internal Medicine Meeting on the health consequences of climate change.

Medications that lower BP reduced CV event rates regardless of prior CVD or baseline BP, according to a meta-analysis published in The Lancet.

Marginalization and stigma are directly related to poor physical and mental health outcomes, according to a speaker at the ACP Internal Medicine Meeting, held virtually.